Table 4 Adverse events in patients with infantile spasms at different time points of follow-up
Adverse events, n (%) | 1 month | 3 months | 6 months | 12 months |
|---|---|---|---|---|
Gastrointestinal disdurbance* | 41 (9.1) | 24 (6.0) | 8 (3.0) | 2 (1.3) |
Constipation | 22 (4.9) | 13 (3.3) | 7 (2.6) | 3 (1.9) |
Fever | 10 (2.2) | 9 (2.3) | 1 (0.4) | 1 (0.6) |
Cold | 6 (0.66) | 2 (0.5) | 3 (1.1) | 0 |
Lack of energy or mental health | 5 (1.1) | 0 | 0 | 0 |
Cough | 3 (0.7) | 4 (1.0) | 0 | 0 |
Anorexia * | 4 (0.9) | 10 (2.5) | 13 (4.9) | 4 (2.5) |
Pneumonia | 4 (0.9) | 9 (2.3) | 6 (2.2) | 0 |
Symptomatic hypoglycemia | 1 (0.2) | 3 (0.8) | 1 (0.4) | 0 |
Enteritis | 1 (0.2) | 0 | 0 | 0 |
Allergy | 1 (0.2) | 1 (0.3) | 0 | 0 |
High triglycerides or cholesterol | 2 (0.4) | 4 (1.0) | 2 (0.8) | 0 |
Kidney stones | 0 | 0 | 0 | 1 (0.6) |
Low bone mineral density | 1 (0.2) | 1 (0.3) | 2 (0.8) | 0 |
Hypoproteinemia* | 0 | 6 (1.5) | 2 (0.8) | 0 |
Continuation of KD (n) | 452 | 397 | 268 | 159 |
Total (%) | 101/452 (22.3) | 86/397 (21.7) | 45/268 (16.8) | 11/159 (6.9) |